Seroprevalence of Anti-Chlamydia Pneumonia Igg in Patients With Respiratory Infection in Diyala Province

Research Article
Fatin Ali Al-Chalabi
Chlamydia pneumonia ,IgG ,Respiratory infection

Background: Chlamydia pneumonia has recently been recognized as a common and important interacellular bacterium implicated in upper and lower respiratory tract infections in humans worldwide Chlamydia pneumonia is one of the major causes of acute respiratory illnesses, including pneumonia ,bronchitis, pharyngitis and sinusitis and chronic obstructive pulmonary disease (CoPD). Objectives: To determine the rate of seroprevalence of Chlamydia pneumonia among patients with respiratory infection in Diyala province.
Subjects and methods : The present study was conducted in Baquba-Diyala province during the period from October /2013 to April/2014.The study group was consist of 91 samples were divided in to tow groups ,healthy and patients. The mean age was 24.09 ± 13.57 years, with an age range 37 day-70 year. Certain demographic factors including age ,residence , sex, type of disease ,previous abortion were collected by personal interview. Detection of anti – Chlamydia pneumonia IgG antibodies was done by Enzyme-Linked Immunosorbant Assay. The Statistical Analysis System- SAS (2012) was used to effect of different factors in study parameters. Chi-square test was used for paired comparison, and percentage value of <0.05 was considered significance
Result: The results show that the positivity rate of anti- Chlamydia pneumonia IgG antibodies in patients was 17.78%. The anti- Chlamydia pneumonia IgG antibodies was statistically higher in the group age more than 20 years ,among male than female , among patients bronchitis, and insignificant between urban and rural population.